{"id":1005669,"date":"2026-09-24T09:05:58","date_gmt":"2026-09-24T13:05:58","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-biopharma-licensee-unbuzzd-wellness-to-advance-clinically-validated-alcohol-metabolism-accelerant-after-appointing-zappy-as-ceo\/"},"modified":"2026-09-24T09:05:58","modified_gmt":"2026-09-24T13:05:58","slug":"quantum-biopharma-licensee-unbuzzd-wellness-to-advance-clinically-validated-alcohol-metabolism-accelerant-after-appointing-zappy-as-ceo","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/quantum-biopharma-licensee-unbuzzd-wellness-to-advance-clinically-validated-alcohol-metabolism-accelerant-after-appointing-zappy-as-ceo\/","title":{"rendered":"Quantum Biopharma Licensee Unbuzzd Wellness to Advance Clinically Validated Alcohol Metabolism Accelerant After Appointing Zappy as CEO"},"content":{"rendered":"
\n

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (FRA: 0K91) (\u201cQuantum BioPharma<\/strong>\u201d), today announced its licensee \u2013 Unbuzzd Wellness Inc. (the “Company<\/strong>” or “Unbuzzd<\/strong>“), the company behind unbuzzd\u2122\u00a0(\u201cunbuzzd<\/strong>\u201d) \u2014 the scientifically-proven and game-changing beverage proven to accelerate alcohol metabolism, restore mental clarity and reduce hangover symptoms, is pleased to announce the appointment of Mr. Michael Zapolin (\u201cZappy\u201d) as CEO. This marks a pivotal milestone in the Company. His mandate includes financing and listing Unbuzzd on a stock exchange and then executing a nationwide commercial marketing and product rollout in the United States.<\/p>\n

Zappy began his career on Wall Street, becoming one of the youngest Vice Presidents at Bear Stearns, before emerging as an early internet entrepreneur behind category-defining domains including Beer.com, Diamond.com and CreditCards.com. He later became an investor and futurist focused on emerging industries, including psychedelics and next-generation wellness. Through initiatives such as the Mushroom Investment Fund, he has backed companies across the psychedelic economy, and he co-founded KetaMD, an at-home ketamine telemedicine company acquired by Braxia Scientific in 2022. Zappy is a graduate of Boston University and Harvard Business School\u2019s Owner\/President Management Program. Playboy Magazine once dubbed Zappy Zapolin \u201cThe Man Who Wants to Change the World with Psychedelics.\u201d He now also wants to change the world with unbuzzd.<\/p>\n

The Company thanks Richard Buzbuzian who was Chief Executive Officer of the Company and is now assisting in the transition to a publicly listed company scheduled to go effective in the next quarter.<\/p>\n

\u201cIn my experience, truly disruptive consumer products are built at the intersection of innovation, proven results and exceptional execution\u2014and I believe unbuzzd has all three,\u201d said Gerry David, Director of Unbuzzd Wellness Inc. \u201cThe clinical validation behind unbuzzd gives us something extremely powerful to bring to consumers and retailers: a product with science supporting what it says it can do. With Zappy\u2019s entrepreneurial track record, ability to build brands and extensive network, I believe we now have the leadership to take that foundation and turn unbuzzd into a significant consumer brand. The opportunity in front of us is substantial, and I am extremely excited about what this team can accomplish.\u201d<\/p>\n

\n Clinically Validated, Science-backed Innovation<\/strong>\n <\/p>\n

unbuzzd stands apart in the\u00a0wellness\u00a0and recovery supplement landscape as the only product backed by a\u00a0peer-reviewed clinical study\u00a0proving its efficacy in accelerating alcohol metabolism, restoring mental clarity, and reducing hangover symptoms. unbuzzd is available for sale on amazon.com and unbuzzd.com.<\/p>\n

The peer-reviewed clinical study, which investigated the effects of unbuzzd on alcohol intoxication and alcohol metabolism, was published in the World Journal of Pharmaceutical and Medical Research (2026, volume 12, issue 3, pages 446-467). The publication can be viewed by clicking the following link:<\/p>\n

\n https:\/\/zenodo.org\/records\/18873638<\/a>\n <\/p>\n

\n Addressing Health-Conscious Consumer Demand<\/strong>\n <\/p>\n

The shift toward\u00a0better-for-you\u00a0beverages continues to accelerate, with\u00a070% of Americans actively seeking health benefits\u00a0from their beverage choices and\u00a072% of Gen Z consumers trying new beverages monthly. unbuzzd addresses this\u00a0consumer demand\u00a0through a\u00a0clean label\u00a0approach\u2014a\u00a0proprietary blend\u00a0of vitamins, minerals, and herbs developed by a world-class R&D team in pharmacology and medicine. Unlike competitors targeting only hydration or hangover symptoms, unbuzzd combines both with\u00a0metabolic\u00a0science in convenient\u00a0ready-to-mix\u00a0powder stick formats.<\/p>\n

\n Scalable Platform for Multi-Channel Distribution<\/strong>\n <\/p>\n

The Company’s\u00a0growth strategy\u00a0targets an expansive retail footprint including pharmacies, liquor stores, supermarkets, mass merchandisers, convenience stores, and college stores\u2014a\u00a0multi-channel distribution\u00a0approach mirroring successful\u00a0nationwide rollouts\u00a0by industry leaders. With\u00a0national distribution\u00a0capabilities and a\u00a0scalable platform\u00a0for both retail and e-commerce, unbuzzd is positioned to capture significant share of the\u00a0total addressable market\u00a0for alcohol recovery and\u00a0functional wellness\u00a0beverages across North America and international markets.<\/p>\n

“As unbuzzd moves to complete its listing on a stock exchange, we are pleased to announce Mr. Zapolin to lead the team,” commented Dr. Eric Hoskins, Director. “With the\u00a0functional beverage market\u00a0on track to exceed\u00a0$198 billion\u00a0and\u00a0consumer demand\u00a0for\u00a0clinically validated,\u00a0better-for-you\u00a0products at an all-time high and Mr. Zapolin\u2019s extensive network, the timing is excellent.”<\/p>\n

“As an advocate for alternative health treatments, I got very excited about unbuzzd a couple of years ago when I heard that the science team had cracked the code\u201d commented Mr. Zapolin, CEO, Unbuzzd Wellness. \u201cWe\u2019ve needed something like this for as long as alcohol has been part of our society.\u201d<\/p>\n

Mr. Zapolin continued, \u201cthe team includes some of the most brilliant people from the beverage industry and scientific community. I believe unbuzzd has the potential to help millions of lives, and I\u2019m honored to help bring it forward.\u201d<\/p>\n

\n About Unbuzzd Wellness Inc.<\/strong>\n <\/p>\n

Unbuzzd Wellness Inc., a non-trading but fully reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. unbuzzd has been developed by a world-class R&D team in pharmacology and medicine, with a commitment to innovation and quality. A proprietary blend of vitamins, minerals, and herbs, unbuzzd helps your body process alcohol faster, restore mental alertness, and improve cognition so you can drink responsibly and drink refreshingly. unbuzzd appeals to a broad target audience of alcohol consumers who want to have a good time, be in control, and still feel great the next day.<\/p>\n

Scientifically backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, unbuzzd dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration (“BAC<\/strong>“), restores mental clarity, and reduces the symptoms of intoxication, impairment and hangover. Key findings from the clinical trial include:<\/p>\n